Islet xenotransplantation: Are we really ready for clinical trials?

American Journal of Transplantation

Volumn 6, Issue 6, 2006, Pages 1269-1274

  Rood, P P M ^a,b   Cooper, D K C ^b  

^a CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

Clinical trials; Pancreatic islets; Xenotransplantation

Indexed keywords

INSULIN;

BIOETHICS; CLINICAL PRACTICE; CLINICAL TRIAL; DIABETES MELLITUS; DISEASE TRANSMISSION; EXPERIMENTAL MODEL; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFECTION RISK; INFORMED CONSENT; INSULIN TREATMENT; MEDICAL DOCUMENTATION; MEDICAL SOCIETY; NONHUMAN; ORGAN DONOR; PANCREAS ISLET TRANSPLANTATION; PATIENT PARTICIPATION; PRIMATE; PRIORITY JOURNAL; REVIEW; SWINE; SWINE DISEASE; THERAPY EFFECT; XENOTRANSPLANTATION;

ANIMALS; CHINA; CLINICAL TRIALS; ENVIRONMENTAL MONITORING; HUMANS; IMMUNOSUPPRESSION; ISLETS OF LANGERHANS TRANSPLANTATION; RUSSIA; SWINE; TRANSPLANTATION, HETEROLOGOUS; TREATMENT OUTCOME; UNITED STATES;

EID: 33745844075     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2006.01336.x     Document Type: Review

References (28)

1. Rood PPM, Buhler LH, Bottino R, Trucco M, Cooper DKC. Pig-to-nonhuman primate islet xenotransplantation: A review of current problems. Cell Transplant (in press).
2. Hering B, Ricordi C. Islet transplantation for patients with type 1 diabetes. Graft 1999; 2: 12-27.
3. Groth CG, Korsgren O, Tibell A et al. Transplantation of porcine fetal pancreas to diabetic patients. Lancet 1994; 344: 1402-1404.
4. Elliott RB, Escobar L, Garkavenko O et al. No evidence of infection with porcine endogenous retrovirus in recipients of encapsulated porcine islet xenografts. Cell Transplant 2000; 9: 895-901.
5. Elliott RB, Escobar L, Tan PLJ, Vasconcellos D, Emerich F, Thanos C. Long term survival of alginate encapsulated piglet islets in a patient with type 1 diabetes (Abstract OP-054). Presented at the 10th Congress of the International Pancreas and Islet Transplantation Association in Geneva 2005.
6. Valdes-Gonzalez RA, Dorantes LM, Garibay GN et al. Xenotransplantation of porcine neonatal islets of Langerhans and Sertoli cells: A 4-year study. Eur J Endocrinol 2005; 153: 419-427.
7. Wang W, Zhaohui M, Bin Y et al. Intra-hepatic artery transplantation of newborn porcine islets (NPI) into 20 type 1 diabetic patients with steroids immunosuppression protocol (Abstract OP-056). Presented at the 10th Congress of the International Pancreas and Islet Transplantation Association in Geneva 2005.
8. McKenzie IFC, d'Apice AJF, Cooper DKC. Xenotransplantation trials. Lancet 2002; 359: 2280-2281.
9. Check E. Diabetes trial stirs debate on safety of xenotransplants. Nature 2002; 419: 5.
10. Korbutt GS, Elliott JF, Rajotte RV. Cotransplantation of allogeneic islets with allogeneic testicular cell aggregates allows long-term graft survival without systemic immunosuppression. Diabetes 1997; 46: 317-322.
11. Dufour JM, Rajotte RV, Korbutt GS, Emerich DF. Harnessing the immunomodulatory properties of Sertoli cells to enable xenotransplantation in type I diabetes. Immunol Invest 2003; 32: 275-297.
12. Wang DZ, Skinner S, Elliot R et al. Xenotransplantation of neonatal porcine islets and Sertoli cells into nonimmunosuppressed streptozotocin-induced diabetic rats. Transplant Proc 2005; 37: 470-471.
13. Isaac JR, Skinner S, Elliot R et al. Transplantation of neonatal porcine islets and sertoli cells into nonimmunosuppressed non-human primates. Transplant Proc 2005; 37: 487-488.
14. Sykes M, d'Apice A, Sandrin M. Position paper of the Ethics Committee of the International Xenotransplantation Association. Xenotransplantation 2003; 10: 194-203.
15. Sykes M, Sandrin M, D'Apice A. Guidelines for xenotransplantation. N Engl J Med 2003; 349: 1294-1295.
16. Sun Y, Ma X, Zhou D, Vacek I, Sun AM. Normalization of diabetes in spontaneously diabetic cynomolgus monkeys by xenografts of microencapsulated porcine islets without immunosuppression. J Clin Invest 1996; 98: 1417-1422.
17. Mueller NJ, Livingston C, Knosalla C et al. Activation of porcine cytomegalovirus, but not porcine lymphotropic herpesvirus, in pig-to-baboon xenotransplantation. J Infect Dis 2004; 189: 1628-1633.
18. Mueller NJ, Fishman JA. Herpesvirus infections in xenotransplantation: Pathogenesis and approaches. Xenotransplantation 2004; 11: 486-490.
19. Blusch JH, Patience C, Martin U. Pig endogenous retroviruses and xenotransplantation. Xenotransplantation 2002; 9: 242-251.
20. Heneine W, Tibell A, Switzer WM et al. No evidence of infection with porcine endogenous retrovirus in recipients of porcine islet-cell xenografts. Lancet 1998; 352: 695-699.
21. Paradis K, Langford G, Long Z et al. Search for cross-species transmission of porcine endogenous retrovirus in patients treated with living pig tissue. The XEN 111 Study Group. Science 1999; 285: 1236-1241.
22. Fishman JA, Patience C. Xenotransplantation: Infectious risk revisited. Am J Transplant 2004; 4: 1383-1390.
23. Fishman J. Xenosis and xenotransplantation: Current concepts and challenges (Abstract PL5.2). Xenotransplantation 2005; 12: 370.
24. Sykes M. Commentary: World Health Assembly resolution 57.18 on xenotransplantation. Transplantation 2005; 79: 636-637.
25. U.S. Department of Health and Human Services Secretary's Advisory Committee on Xenotransplantation (SACX). Informed consent in clinical resarch involving xenotransplantation. http://www4.od.nih.gov/oba/sacx.html.
26. Cooper DKC. Draft reports for public comment from the U.S. Secretary's Advisory Committee on Xenotransplantation. Xenotransplantation 2005; 12: 255-257.
27. Jie T, Graham M, Wijkstrom M et al. Pancreatic islet xenotransplants restore normoglycemia and insulin independence in immunosuppressed non-human primates. Abstract O471, presented at the 20th International Congress of the Transplantation Society in Vienna. Transplantation 2004; 78: 185.
28. Cooper DKC, Keogh AM, Brink J et al. Report of the Xenotransplantation Advisory Committee of the International Society for Heart and Lung Transplantation: The present status of xenotransplantation and its potential role in the treatment of end-stage cardiac and pulmonary diseases. J Heart Lung Transplant 2000; 19: 1125-1165.